Hos kaniner var den systemiske eksponering af den højeste dosis kun 0, 3 gange den dosis for human eksponering ved maksimum klinisk dosis og derfor er den udviklingsrelaterede toksicitet af fosamprenavir ikke klarlagt.
In rabbits, systemic exposure at the high dose level was only 0.3 times human exposure at the maximum clinical dose and thus the development toxicity of fosamprenavir has not been fully determined.